Tag:
Sanofi
Latest Headlines
Latest Headlines
Another one bites the dust: Plavix falls off patent today
Yet another milestone on pharma's journey away from the megablockbuster era: Plavix, the gold-standard clotbuster, goes off patent today.
Buzz: Big Pharma suitors line up for a look at Amylin's books
One of the cardinal rules involved in deal-making focuses on the need to get as many buyers to the negotiating table as possible. The next big rule: Make sure everyone knows who's interested in bidding.
Shantha gets go-ahead for operational revamp
Sanofi's plan for revamping Shantha Biotech won Indian government approval, clearing the way for it to recapture WHO contracts for its Shan5 vaccine.
Indian gov't probes drug regulator after scathing review
Days after a parliamentary report noted shoddy oversight of approvals, the Indian government has mounted an investigation into the alleged misdeeds. Meanwhile, big names in biopharma have surfaced in the sea of allegations.
Indian panel accuses Big Pharma of colluding with regulators
An Indian government report has hit the domestic pharma business like a whirlwind--and sucked Big Pharma into the fury.
Subpar clinical trials probed in India's review of regulation
Indian lawmakers and patient advocates charge that their regulator rubber-stamped drugs to be sold in the county without required clinical trials.
Ex-Sanofi chemist locked up after theft
After being accused of bilking her former employer, a court sentenced ex-Sanofi chemist Yuan Li to serve a year and half in prison and pay $131,000 in restitution, Pharmalot reported, citing court documents.
Sanofi plant starts shutdown with 112 layoffs
Long slated for closure, a Sanofi plant in Missouri is starting to unwind.
Sanofi closing plant in Missouri, 4 years later than expected
The company tells The Kansas City Star that layoffs will occur about every 6 months beginning with the loss of 112 jobs June 1. There are 337 workers currently.
Genzyme's $150M plant upgrade starts to pay off
The company says in a release that the FDA and the EMA have given approval to a filling and finishing operation for Myozyme and Lumizyme, treatments for the enzyme deficiency known as Pompe disease.
